Screener
Beta Bionics BBNX Total Cost of Revenue
Total Cost of Revenue at other companies
Other financials
Where this comes from
Reported directly by Beta Bionics in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The source filing: Beta Bionics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323777
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Net sales | $32,013 | $23,238 | $59,639 | $40,877 |
| Cost of sales | 13,111 | 10,735 | 24,300 | 19,403 |
| Gross profit | 18,902 | 12,503 | 35,339 | 21,474 |
| Operating expenses: | ||||
| Research and development | 10,240 | 8,873 | 20,596 | 16,463 |
| Sales and marketing | 24,640 | 15,623 | 45,375 | 29,025 |
| General and administrative | 9,600 | 7,879 | 19,217 | 14,500 |
| Total operating expenses | 44,480 | 32,375 | 85,188 | 59,988 |
Item 1. Financial Statements.
FAQ
- What is Beta Bionics's total cost of revenue?
- Beta Bionics (BBNX) reported total cost of revenue of $13.11M in Q2 2026.
- How has Beta Bionics's total cost of revenue changed year-over-year?
- Beta Bionics's total cost of revenue increased by 22.1% year-over-year, from $10.74M to $13.11M.
- What is the long-term trend for Beta Bionics's total cost of revenue?
- Over 2 years (2023 to 2025), Beta Bionics's total cost of revenue has grown at a 180.4% compound annual growth rate (CAGR), from $5.69M to $44.71M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.
Ask your AI about Beta Bionics's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude